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Abstract
Prions are self-perpetuating aggregated proteins that are not limited to mammalian systems but also exist in lower
eukaryotes including yeast. While much work has focused around chaperones involved in prion maintenance, including
Hsp104, little is known about factors involved in the appearance of prions. De novo appearance of the [PSI+] prion, which is
the aggregated form of the Sup35 protein, is dramatically enhanced by transient overexpression of SUP35 in the presence of
the prion form of the Rnq1 protein, [PIN+]. When fused to GFP and overexpressed in [ps2] [PIN+] cells, Sup35 forms
fluorescent rings, and cells with these rings bud off [PSI+] daughters. We investigated the effects of over 400 gene deletions
on this de novo induction of [PSI+]. Two classes of gene deletions were identified. Class I deletions (bug1D, bem1D, arf1D,
and hog1D) reduced the efficiency of [PSI+] induction, but formed rings normally. Class II deletions (las17D, vps5D, and
sac6D) inhibited both [PSI+] induction and ring formation. Furthermore, class II deletions reduced, while class I deletions
enhanced, toxicity associated with the expanded glutamine repeats of the huntingtin protein exon 1 that causes
Huntington’s disease. This suggests that prion formation and polyglutamine aggregation involve a multi-phase process that
can be inhibited at different steps.
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Introduction
Prions are associated with transmissible spongiform encepha-
lopathies, a family of neurological diseases that include Creutz-
feldt-Jakob disease in humans, Scrapie in sheep, and the well-
publicized ‘‘Mad Cow’’ disease. Transmission of prions occurs
when a normally folded protein is converted to an alternate
conformation that has the ability to further convert additional
molecules of the normal protein into the misfolded infectious form.
Prions also exist in Saccharomyces cerevisiae. The well characterized
cytoplasmically transferred elements [URE3], [PSI+], and [PIN+]
(see reviews [1–4]), as well as several other recently characterized
elements [5–9], have been identified as yeast prions.
Prions occur spontaneously in laboratory strains, although at
very low frequency [10–12]. De novo appearance of prions can be
facilitated by overexpression of either the whole prion protein or
distinct regions that are required for propagation, called prion
domains [13–19]. Most known yeast prion domains are glutamine
(Q) and asparagine (N) rich [3,5–9,20]. In the case of de novo
appearance of the prion form of the Sup35 translational
termination factor, [PSI+], overexpression of Sup35 or its prion
domain (Sup35PD) dramatically increases the appearance of
[PSI+]. However, this increase requires either Q/N-rich domains
that are simultaneously overexpressed [21,22] or the presence of
another Q/N rich prion, like the prion form of the Rnq1 protein,
[PIN+] (also called [RNQ+]; [22–24]).
Similar to prion strains found in mammals (reviewed in [25]),
yeast prions have also been shown to exist in different conformations
called ‘‘variants’’ [14,26–30]. The introduction of in vitro generated
Sup35 amyloid fibers into yeast not only infects the cells with the
prion, proof of the ‘‘protein-only’’ hypothesis, but also demonstrates
that distinct forms of the in vitromade amyloid cause the appearance
of distinct variants that are heritable [31–32].
To further understand how prions are formed and maintained,
recent studies have focused on specific host factors that affect the
propagation and appearance of yeast prions. Chaperones, which
are normally involved in proper protein folding, play a role in
prion maintenance and appearance. Hsp104 and Sis1 break prion
aggregates into smaller pieces that efficiently segregate into
daughter cells, a requirement for prion transmission [33–41].
Deletion of the N-terminal activation domain of Hsf1, a heat shock
transcription factor, prevents [PSI+] formation, while deletion of
the Hsf1 C-terminal region promotes [PSI+] appearance [42].
Furthermore, disruption of the non-essential human Hsp110
ortholog, SSE1, or overexpression of HSP82 and HSC82 that
encode members of the Hsp90 family of chaperones, dramatically
reduces, but does not eliminate, the induction of [PSI+] caused by
the overexpression of Sup35PD [43].
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Factors that affect [PSI+] induction are not limited to
chaperones. Deletion of actin cytoskeletal genes, such as SLA1 or
SLA2, reduces [PSI+] induction [44], suggesting that the actin
cytoskeleton may play a role in prion appearance. Deletion of the
ubiquitin-conjugating enzyme, Ubc4, enhances the de novo
appearance of [PSI+] [45], and exposure to environmental stress
can also alter the frequency of [PSI+] appearance [46].
Here, we identify deletions of several genes (bug1D, bem1D,
arf1D, hog1D, las17D, vps5D, and sac6D) that reduce the efficiency
with which overexpression of Sup35PD can induce the de novo
appearance of [PSI+]. Deletion of LAS17, VPS5, or SAC6, which
are associated with endocytosis and the actin cytoskeleton, not
only inhibit [PSI+] induction, but also suppress the toxicity and
aggregation associated with the expanded glutamine repeats of the
huntingtin protein exon 1 that causes Huntington’s disease.
Results
Deletions of BUG1, BEM1, ARF1, HOG1, LAS17, VPS5, and
SAC6 show low or no induction of [PSI+] but maintain
propagation of [PSI+] and [PIN+]
Our goal was to identify genes that influence the induction of
the [PSI+] prion. Previous work approached this problem by
making use of the observation that overexpression of Sup35PD-
GFP in [PSI+] [PIN+] cells causes toxicity due to excessive
sequestration of essential Sup35 into large aggregates [46,47].
When Sup35PD-GFP is highly overexpressed in [psi2] [PIN+]
cells, the frequent induction of [PSI+] results in an intermediate
level of toxicity, because only cells that have switched to the [PSI+]
state are sick [23,46]. Therefore, genes whose deletions enhance or
reduce the toxicity associated with overexpression seemed likely to
increase or decrease [PSI+] induction frequency, respectively [46].
We tested 238 deletion strains that enhanced toxicity, 151 that
reduced toxicity, and nine other strains studied in Tyedmers et al.
[46] (Table S1; Tyedmers and Lindquist, unpublished) for their
effects on [PSI+] induction.
First, to distinguish the inability to induce [PSI+] from the
inability to propagate [PSI+] we tested if the 398 deletions could
maintain weak and strong variants of [PSI+] in a propagating
culture after cytoduction with [PSI+]. A plasmid encoding a copper
inducible Sup35PD-GFP fusion was plasmiduced into the deletion
strains simultaneously with the cytoduction of weak or strong
[PSI+]. After over 50 generations of growth, we scored for
maintenance of [PSI+] by overexpressing Sup35PD-GFP and
examining cells for the presence of fluorescent aggregates. All
deletion strains cytoduced with either weak or strong [PSI+]
contained fluorescent aggregates, indicative of [PSI+], except for
hsp104D, which had the characteristic diffuse fluorescence of [psi2]
cells (data not shown). Additionally, we have previously shown that
[PIN+] is maintained in all strains of the deletion library except
rnq1D and hsp104D [48].
Next, we used a standard nonsense suppression assay for [PSI+]
to screen the 398 yeast deletion library strains, in the BY4741
background, for their effects on induction of stable propagating
[PSI+]. To do this, the [PIN+] prion, the Sup35PD-GFP plasmid,
and a plasmid containing a ura3–14 nonsense allele to score for
[PSI+] cells [49] were simultaneously cytoduced into the 398
deletion strains as described previously [48]. Following overex-
pression of Sup35PD-GFP to induce [PSI+], cells were plated on–
Ura where suppression of the plasmid borne ura3–14 nonsense
allele allowed [PSI+], but not [psi2], cells to grow.
Six novel deletion strains: bem1D, def1D, scp160D, rpp1aD, spt4D,
and pre9D, as well as the expected rnq1D and hsp104D deletions,
failed to grow on -Ura (Table 1). Previous work has shown that in
the presence of the SUP35 R2E2 allele, which increases the
appearance of [PSI+] without SUP35 overexpression, bem1D and
pre9D decreased [PSI+] appearance [46]. In addition, 29 other
deletions showed either low or extremely low induction of [PSI+]
(Figure 1; Table 1). While strains carrying deletions of SPT4 or
YML010C-B failed to express Sup35PD-GFP, all other deletion
strains expressed Sup35PD-GFP at similar levels (data not shown).
Deletion strains that decrease the efficiency of [PSI+] induction
(Table 1) were from both enhanced and reduced toxicity groups.
This makes sense if we consider that toxic side effects of the
deletions could overlay the positive effect on growth rate due to the
Author Summary
Certain proteins that exist in functional unaggregated
conformers can also form self-perpetuating infectious
aggregates called prions. Here we investigate factors
involved in the initial switch to the prion form. De novo
appearance of the [PSI+] prion, which is the aggregated
form of the Sup35 protein, is dramatically enhanced by
overexpression of the SUP35 gene in the presence of the
prion form of the Rnq1 protein, [PIN+]. When tagged with
green fluorescent protein and transiently overexpressed in
[psi2] [PIN+] cells, Sup35 forms fluorescent rings, and cells
with these rings give rise to daughter cells that are [PSI+].
Here, we investigate factors required for this induction of
[PSI+]. Analyses of over 400 gene deletions revealed two
classes that reduce [PSI+] induction: one class forms
fluorescent rings normally, and the other does not.
Interestingly, the former class enhanced, while the latter
class reduced, toxicity associated with the expanded
polyglutamine repeats of the huntingtin protein exon 1
that causes Huntington’s disease. These results suggest
that prion formation and polyglutamine aggregation
involve a multi-phase process that can be inhibited at
different steps.
Table 1. Yeast deletion library strains that show no, very low,
or low induction of [PSI+].
Deletions that fail to induce [PSI+]
bem1D*- hsp104D- rnq1D*- scp160D*-
def1D*- pre9D* rpp1aD*+ spt4D{-
Deletions that show very low induction of [PSI+]
ase1D*- bfr1D*- hog1D*+ rpl20bD*-
arf1D*- bre1D*+ hop2D{- ycl005wD{-
Deletions that show low induction of [PSI+]
ada2D+ nas2D*+ snf8D+ ydr048cD{+
asc1D+ new1D+ swa2D*+ yhr033wD+
bug1D*+ pub1D- trf5D*+ yml010c-bD{-
cik1D*+ sac1D+ tsr2D+
gvp36D+ sgf73D+ vid22D+
lst7D*+ slg1D+ ydl032w+
*Re-engineered deletion.
{Unable to obtain deletion.
{Showed extremely low induction of Sup35PD-GFP.
+enhanced toxicity as described by Tyedmers et al., unpublished.
-reduced toxicity as described by Tyedmers et al., unpublished.
doi:10.1371/journal.pgen.1001386.t001
Two Gene Classes Control Prion and PolyQ Formation
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reduced [PSI+] induction. Furthermore, in some deletions, even
the overexpression of YFP alone (without the Sup35 prion
domain) causes strong toxicity that must be, therefore, completely
unrelated to prion induction frequency [46].
To eliminate the effects of secondary mutations known to have
accumulated in library strains [50,51], multiple independent
deletions of nineteen of the best candidates that showed no or
reduced induction of [PSI+] (Table 1) were re-engineered in a
wildtype 74-D694 [PIN+] strain. This 74-D694 genetic back-
ground contains a [PSI+] suppressible ade1–14 allele that provides
the ability to directly score for [PSI+] by examining growth on -
Ade. Of the 19 re-engineered deletions, only the six deletions
(bre1D, bug1D, bem1D, arf1D, pre9D, and hog1D) that reproducibly
reduced the frequency of [PSI+] induction, relative to the wildtype
induction frequency of approximately 7.5 X 1023 (Figure 2), were
pursued further. Since a slow growth phenotype complicates the
scoring for [PSI+], deletions that significantly inhibited growth in
the 74D-694 background, like lst7D and swa2D (data not shown),
were eliminated from further analysis.
In addition to the above deletions, we made a deletion of LAS17,
which was previously shown to inhibit the aggregation of the
polyglutamine 103Q repeat [52]. We also made deletions of VPS5
and SAC6, because they, like Las17 and other proteins shown to
affect the appearance of [PSI+], are associated with endocytosis
and the actin cytoskeleton. Even though prion propagation is
unaffected in these three deletion strains because they were all able
to maintain [PSI+] over many generations after cytoduction (data
not shown), vps5D caused a significant decrease in prion induction,
and las17D and sac6D strains completely failed to induce [PSI+]
(Figure 2).
To eliminate deletions that reduced [PSI+] induction by altering
the levels of Sup35, Sup35PD-GFP, or chaperones, we examined
these levels in all strains. None of the deletions caused significant
changes in Hsp104, Ssa1, Sis1, Sse1, or Ssb1/2 (data not shown).
Since Sup35PD-GFP levels were reduced in bre1D strains and
Sup35 endogenous levels were decreased in pre9D strains (Figure
S1), these deletions were dropped from further study.
To eliminate the possibility that the reduced [PSI+] induction
was due to the loss of [PIN+] during the construction of any of the
deletion strains, we showed that the maintenance of [PIN+] was
unaffected by the deletions. Each independently constructed
deletion was crossed to a [pin-] strain carrying a plasmid with
the CUP1 controlled RNQ1-GFP fusion. When grown on medium
containing copper, induction of the resulting diploid containing
the RNQ-GFP construct caused the appearance of punctate dots
indicative of [PIN+] (data not shown). Furthermore, we showed
that [PIN+] was maintained in deletion strains by the presence of
[PIN+] characteristic SDS-resistant oligomeric species after
24 hours of Sup35PD-GFP overexpression (Figure S2). Differenc-
es in the migration of Rnq1 SDS-resistant oligomers have been
shown to be associated with different [PIN+] variants [53]. We
observed similar migration of Rnq1 oligomeric species in the
deletion strains, suggesting that the [PIN+] prion variants were not
altered during construction of the strain or by Sup35PD-GFP
overexpression. These results and other properties of the deletions
investigated further below are summarized in Table 2.
Figure 1. Scoring for [PSI+] induction in deletion strains. All deletion library candidates in the BY4741 background were cured on GuHCl and
cytoduced using kar1 donor strains containing the Sup35PD-GFP and ura3–14 plasmids and either high [PIN+] (right) or [pin2] (left). Expression of
Sup35PD-GFP was induced on plasmid selective media containing 50 mM copper for two days and then spotted either onto -Ura to score for [PSI+]
induction or +Ura to assay growth. All cytoductions were performed in duplicate and cytoductants were tested for the ability to induce [PSI+] multiple
times. Control strains (top row) show growth on -Ura in [PIN+], but not [pin2], strains after 8 days. Both rnq1D (second row) and bem1D (third row)
strains show no growth on -Ura after 11 days, indicative of no [PSI+] induction. Deletion strains showing very low induction, e.g. arf1D, exhibit very
few colonies after 11 days of growth on -Ura (fourth row), whereas strains showing low induction (e.g. bug1D, last row) show slow growth on -Ura
after eight days.
doi:10.1371/journal.pgen.1001386.g001
Two Gene Classes Control Prion and PolyQ Formation
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Reduced [PSI+] formation is not always associated with
reduced ring formation
Transient overexpression of Sup35PD-GFP in [psi2] [PIN+]
cells leads to the appearance of cytoplasmic fluorescent rings and
lines [54]. Daughter cells derived from micromanipulated cells
that contain such rings or lines, where overexpression of
Sup35PD-GFP is turned off but where endogenous SUP35 is
tagged with GFP, always contained fluorescent punta indicative of
[PSI+] [55]. In contrast, mother cells without ring or line
aggregates always gave rise to daughter cells with diffuse
fluorescence, indicative of [psi2] [44,54–56]. Thus the appearance
of rings/lines, while not necessarily a direct intermediate in the
formation of [PSI+], is nonetheless a hallmark of the potential
appearance of induced [PSI+]. No such rings have ever been
observed during spontaneous appearance of [PSI+] in the absence
of Sup35PD overexpression (unpublished).
To determine the deletions that inhibit the induction of [PSI+]
and also prevent ring formation, we compared the number of cells
that contained rings after 24 hours of expressing Sup35PD-GFP in
the seven deletion strains. Ring containing cells in four of the
deletions, bug1D, bem1D, arf1D, and hog1D, appeared at levels
similar to wildtype (30%, Figure 3A). The rnq1D strains, which are
[pin2], always displayed diffuse fluorescence (Figure 3A), as
expected, since [PIN+] has been previously shown to be required
for ring formation [54].
Interestingly, when measured after 24 hrs of Sup35PD-GFP
induction, the three deletions associated with endocytosis and
organization of the actin cytoskeleton, sac6D, las17D, and vps5D, all
showed a significant reduction in cells containing rings. Since by
25 hrs of induction, wildtype, sac6D, and vps5D cultures were in
stationary phase, where ring formation peaks [54], the inhibition
of ring formation in sac6D and vps5D was not the result of a failure
of these cultures to reach stationary phase (Figure S3). Also, since
las17D cells reached saturation phase only after 36 hours, we also
measured ring formation in las17D cultures following 50 hrs of
induction, well after the culture reached stationary phase. These
cultures still showed a 50% reduction in ring formation relative to
the wildtype cultures (data not shown).
Ring-associated toxicity
Ring formation is associated with [PSI+] appearance [54].
However, it has been shown that cells that contain rings have a
higher rate of cell death than those that have diffuse fluorescence
[44,47,54]. Therefore, we asked if the deletions might be more
toxic to ring bearing cells, which would result in a decrease in
[PSI+] induction. To test this, we micromanipulated individual
ring containing cells from selected deletion strains and assessed
whether they were viable. Similar to previous findings [47], only
36% of wildtype ring containing cells were viable, whereas 95% of
wildtype cells with diffuse cytoplasmic fluorescence were viable
(Figure 3B). In general, the viability of ring containing wildtype,
bem1D, and hog1D cells appeared to be similar (Figure 3B) and
therefore cannot explain the strong reduction of de novo induction
of [PSI+]. Ring containing arf1D cells had reduced viability (21%),
which could account for the decrease in [PSI+] induction (Figure 2).
In contrast, bug1D ring cells showed an increase in viability (59%),
Figure 2. Nine deletions show reduced [PSI+] appearance. Genes were disrupted in the 74D-694 [PIN+] strain background. Deletion strains,
transformed with the Sup35PD-GFP plasmid, were grown in 10 ml of plasmid selective media supplemented with copper for 24 hours at 30uC and
plated on SD-Ade in order to determine [PSI+] induction frequency. Induction frequency and standard error were calculated with at least one
transformant from each independent knock out (see Table S3) for a total of three transformants per deletion. The exception was pre9D which was
calculated from three transformants from a single independent knock out. Only deletion strains that showed a significant difference in induction
frequency compared to wildtype strains (p,0.05 unpaired t-test) were included in the figure.
doi:10.1371/journal.pgen.1001386.g002
Two Gene Classes Control Prion and PolyQ Formation
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Figure 3. Ring formation and viability. A. [PIN+] cells containing Sup35PD-GFP were induced in copper containing liquid media for 24 hours. The
percentage of cells containing rings was determined by counting more than 300 cells from at least one transformant from each independent
knockout line (see Table S3) for a total of three transformants per deletion. Bars indicate standard error and (*) indicates deletion strains that showed
a significant difference in the percentage of cells containing rings compared to wildtype (p,0.01 unpaired t-test). B. Ring containing cells (purple
bars) or cells with diffuse cytoplasmic fluorescence (green bars) were isolated by micromanipulation, placed on rich media and assayed for growth. At
least 20 ring containing cells and 10 diffuse cells, from at least one transformant from each independent knock out line for a total of three
transformants, were tested. Bars indicate standard error and (*) indicates the deletion strains that showed a significant difference in viability
compared to wildtype strains (p,0.01 unpaired t-test).
doi:10.1371/journal.pgen.1001386.g003
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but apparently these cells did not efficiently give rise to [PSI+] cells.
In the absence of rings, there appeared to be no effect on the
viability of any of the deletion strains (Figure 3B, green bars).
Since isolating ring cells in strains with low ring formation was
difficult, we focused on one example and found that of the small
population of cells in vps5D strains that formed rings, a majority
were inviable (Figure 3B). This suggests that rings in the absence of
VPS5 may be harmful to the cell and likely explains the decreased
percentage of rings observed in Figure 3A.
Deletion strains affect aggregation and toxicity of
polyglutamine
We next asked if our deletion strains also affect the [PIN+]
dependent aggregation of the polyglutamine (polyQ) expanded
repeat found in the mutant huntingtin protein associated with
Huntington’s disease. Since las17D strains, carrying a galactose
inducible expanded polyQ repeat (103Q) fused to GFP, were
previously shown to delay 103Q-GFP aggregate formation
compared to wildtype strains [52], we tested our other deletions
for similar aggregation patterns. When wildtype [PIN+] cells
expressed 103Q-GFP for approximately one to two hours, 82% of
cells displayed strong fluorescent puncta, while [pin-] cells showed
mostly cells with diffuse fluorescence (73%) and a minor
population that contained a few faint fluorescent foci on a diffuse
background (27%; Figure 4A and 4B). Similar analyses of [PIN+]
strains with bug1D, bem1D, arf1D, and hog1D deletions resulted in a
reduced number of cells that contained strong fluorescent puncta
(Figure 4B, green bars) and an increased number of cells that had
faint fluorescent foci with a diffuse background (Figure 4B, purple
bars). As in the previous study [52], [PIN+] las17D strains had
barely any strong fluorescent foci. Examination of [PIN+] vps5D
and [PIN+] sac6D strains also showed a strong reduction in cells
having bright foci and a similar distribution of cells with faint foci
vs. no foci as seen in wildtype [pin-] strains.
We next examined the effect of these deletions on toxicity
associated with expression of the expanded polyglutamine protein
in the presence of the [PIN+] prion [57]. Our controls verified
earlier findings [57] that wildtype [PIN+] cells carrying a galactose
inducible 103Q-GFP plasmid show toxicity compared to cells
carrying the non-toxic 25Q-GFP plasmid. As expected, polyglu-
tamine expressing cells that are either [pin-] or rnq1D did not
exhibit toxicity, whereas wildtype [PIN+] cells were sick
(Figure 4C). Since previous studies have correlated the presence
of polyQ aggregates with cell toxicity [57], the lack of strong
polyQ fluorescent foci in the class of deletions that also reduced
ring formation after Sup35PD-GFP overexpression (las17D, vps5D,
and sac6D; Figure 4A and B) nicely explained the observed
decrease in polyQ toxicity. Interestingly, the class of deletions that
reduced [PSI+] induction, but not ring formation (bug1D, bem1D,
arf1D, and hog1D), increased the frequency of cells containing faint
polyQ-GFP fluorescent foci on diffuse backgrounds and clearly
enhanced 103Q toxicity.
Discussion
We scored 398 gene deletions, previously identified by their
ability to increase or decrease toxicity caused by overexpression of
Sup35PD-GFP [46], for effects on the induction of [PSI+] and
established effects for four of the deletions (see Table 2
summarizing all results). Since there is not always a strong
correlation between the toxicity associated with SUP35 overex-
pression and the induction of [PSI+], we tested all of the enhanced
and reduced toxicity candidates found in the previous study [46]
for [PSI+] induction. We observed that induction of [PSI+] was
inhibited by deletions that either reduced (arf1D and bem1D) or
enhanced (bug1D and hog1D) toxicity. Possibly the rings or other
less visible aggregates have an altered property in the presence of
bug1D or hog1D that inhibits detectable [PSI+] appearance and
causes toxicity. It has been shown that rings cause toxicity by
titrating Sup35 and/or Sup45 (the essential release factor that
binds to Sup35) into aggregates and away from the ribosome [46].
The toxicity associated with bug1D and hog1D during [PSI+]
induction could be an enhancement of this effect or could be by
the formation of a different type of toxic [PSI+] intermediate.
We also examined three deletions (las17D, vps5D, and sac6D),
which were chosen for their association with endocytosis and the
actin cytoskeleton, and found that they reduce [PSI+] induction.
While las17D and vps5D were not included in the library originally
scored for SUP35PD-GFP toxicity, the sac6D BY4741 library
strain was not associated with changes in toxicity [46]. We found
that sac6D inhibits [PSI+] induction in both the deletion library
(BY4741; data not shown) and the 74-D694 (Figure 2) back-
grounds. This suggests that other non-essential deletions that
inhibit [PSI+] induction were likely missed in the toxicity screen.
All seven of our deletion strains reduce [PSI+] induction caused
by overexpression of Sup35PD-GFP. While a deletion of BEM1
was previously shown to reduce the spontaneous appearance of
[PSI+] associated with the SUP35 R2E2 expanded repeat [46], it is
unknown whether our deletions affect the spontaneous appearance
of [PSI+] without overexpression or mutated alleles (e.g. R2E2) of
Sup35. Since the spontaneous appearance of [PSI+] is very
infrequent and Mendelian suppressors with the phenotype of
[PSI+] [58] appear at a higher rate than [PSI+], scoring for
mutations that lower the appearance of [PSI+] is challenging.
Prion and polyglutamine formation and maturation
Time lapse examination of individually micromanipulated
[psi2] [PIN+] cells, containing an endogenously tagged Sup35-
GFP fusion and transiently overexpressing Sup35PD-GFP from a
plasmid, previously showed that a fluorescent ring initially forms at
the cell periphery and then internalizes around the vacuole. Later,
such cells with rings give rise to [PSI+] daughter cells with
fluorescent foci (Figure 5A) [44,55].
In this paper, we identified two classes of gene deletions that
reduce the de novo induction of stable [PSI+] but differ in effects on
ring formation. Class I deletions (bug1D, bem1D, arf1D, and hog1D)
form Sup35PD-GFP rings at approximately wildtype levels
(Figure 3). Class II deletions (las17D, vps5D, and sac6D) have a
significantly reduced number of cells with Sup35PD-GFP rings
(Figure 3).
The existence of these two deletion classes suggests that the
prion formation pathway can be inhibited at different steps. In the
case of class I deletions, problems in peripheral and internal ring
formation were not detected (data not shown), suggesting that
these genes are important for ring containing cells to transmit
heritable [PSI+] aggregates to daughter cells (Figure 5A). In the
case of class II deletions, peripheral rings form infrequently,
suggesting that these genes are important in the initial formation of
the ring even in the presence of [PIN+] (Figure 5A). While rings
contained in vps5D (class II) cells have reduced viability, it is
unlikely that ring formation is so toxic that cells die before the ring
appears because there is no corresponding increase in toxicity in
non-ring containing cells (Figure 3B).
The formation of polyglutamine aggregates, upon overexpres-
sion of Q103:GFP in a [PIN+] strain, is not associated with ring
formation. Instead, large bright aggregates are observed within
one to two hours of induction [52]. All of our deletions affected
polyglutamine aggregation, but the type of effect differed based on
Two Gene Classes Control Prion and PolyQ Formation
PLoS Genetics | www.plosgenetics.org 7 May 2011 | Volume 7 | Issue 5 | e1001386
Figure 4. Aggregation and toxicity of 103Q in deletion strains. A. Log phase wildtype [PIN+] cells containing the 103Q-GFP plasmid were
induced in galactose containing media for one to two hours and then visualized. Within the population, most cells exhibited strong fluorescent
aggregates on a non-fluorescent background (bottom), some cells had faint fluorescent foci on a cloudy fluorescent background (middle), and a very
small population of cells had diffuse cytoplasmic fluorescence (top). B. Deletions containing 103Q-GFP were induced and scored for the different cell
types indicated in (A). The percentages of cells containing strong fluorescent aggregates (green bars), faint foci (purple bars), and diffuse cytoplasmic
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the class of the deletion. Class I deletions (bem1D, bug1D, arf1D, and
hog1D) caused a decreased level of bright fluorescent aggregates
and an increase in diffuse cells with faint foci (Figure 4A and 4B).
Interestingly, these deletions enhanced the toxicity associated with
103Q-GFP (Figure 4C). In the presence of the class II deletions
(las17D, vps5, and sac6D) 103Q-GFP usually remained diffuse, and
Figure 5. Proposed effects of class I and II genes on the multistep pathways of de novo prion and polyglutamine aggregate
formation. A. Induction of [PSI+] by transient overexpression of Sup35PD-GFP in a [psi2] [PIN+] strain with endogenous Sup35 tagged with GFP. As
described in Mathur et al., [55] the first stages of [PSI+] induction involve the formation of a peripheral fluorescent ring. Class II deletions appear to
inhibit this step. As the ring matures, diffuse Sup35 diminishes in intensity. The peripheral ring then collapses to surround the vacuole. The daughters
of the ring containing cell contain multiple Sup35:GFP aggregates characteristic of [PSI+]. Class I deletions interfere with transitioning to [PSI+] after
the ring appears. B. Hypothetical model of 103Q aggregation in [PIN+] cells. Class II proteins function in the initial formation of small toxic 103Q
oligomers (left), since class II gene deletions result in diffuse fluorescence and suppression of toxicity. Class I proteins most likely facilitate
incorporation of these small oligomers into large protective aggregates (right).
doi:10.1371/journal.pgen.1001386.g005
fluorescence (gray bars) were calculated from over 300 cells from at least one transformant from each independent knock out line for a total of three
transformants. C. Wildtype [PIN+], wildtype [pin2], rnq1D, and the indicated [PIN+] deletion strains were transformed with either the 103Q-GFP or 25Q-
GFP plasmid and grown to late log phase in glucose (uninducing) media. Cells were serially diluted 20-fold and plated on media that either induced
(right column; galactose containing media) or did not induce (left column; glucose containing media) the overexpression of the 25Q-GFP or 103Q-
GFP plasmid. White arrowhead indicates the lowest dilution displaying growth. Deletion strains in (C) are in the 74D-694 background except sac6D,
which is in the BY4741 [PIN+] background as indicated. Pictures shown are representative of the multiple independent deletion lines tested for 103Q-
GFP toxicity.
doi:10.1371/journal.pgen.1001386.g004
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very few cells had bright aggregates (Figure 4B). Additionally, all
class II deletions suppressed polyglutamine toxicity (Figure 4C).
The formation of large huntingtin aggregates in mammals was
initially thought to be the cause of huntingtin-mediated cell death
(reviewed in [59]), but emerging evidence suggests that these large
aggregates are neuroprotective ([60], reviewed in [61]) and toxicity
is due to a soluble pool of oligomeric conformers [62-63]. Also in
yeast, small multiple foci of 103Q appear to be more toxic than a
large aggregate [64,65]. Thus, we propose that class I genes are
important for the formation of large protective aggregates but not
small toxic oligomers (Figure 4B), and that when a class I gene
product is absent, the reduction of large protective aggregates
permits the increased propagation of deadly soluble oligomers.
In contrast, in cells with class II deletions, 103Q-GFP toxic
oligomers or aggregates may form only rarely. While the [PSI+]
and polyglutamine formation pathways are not directly compara-
ble, we propose that class II genes affect the initial steps of
polyglutamine formation, and the formation of large protective
aggregates (promoted by class I genes) is a downstream event
(Figure 5B).
Actin and prion formation
Although endocytosis is relatively unaffected in bem1D, bug1D,
arf1D, hog1D, las17D, vps5, and sac6D strains, six out of seven of our
deletion mutants display fragmented vacuoles (Figure S4) [66,67].
Possibly, vacuole fragmentation may affect the perivacuolar
deposition site for aggregated proteins, called IPOD [68], which
has been suggested to play a role in prion formation [55,56]. Some
of the deletion library strains we screened induced [PSI+] normally
but had fragmented vacuoles (Table SI, asterisk; [66]), suggesting
that intact vacuoles are not necessarily a requirement for efficient
prion appearance. Vacuole fragmentation has been shown to be
associated with microtubular defects [69] as well as fluctuations in
the soluble actin pool [67]. We showed that treatment with the
microtubule disrupting drugs Nocodazole (Figure S4B and S4C)
and Thiabendazole (data not shown) at concentrations that did not
inhibit Sup35PD-GFP induction do not affect [PSI+] appearance.
Conversely, the actin disrupting drug Latrunculin A [70] and act1-
R117A alleles [44] do inhibit [PSI+] induction. Furthermore, many
of the deletions identified in this study are involved with actin
(Table 2), suggesting that actin organization plays a critical role in
the aggregation of prion and polyglutamine proteins.
Possibly, proper actin organization on the cell periphery is
required for the initial formation of the [PSI+] ring or
polyglutamine oligomers, where as actin organization elsewhere
in the cell could be required for downstream events such as the
formation of a propagating [PSI+] conformer or the formation of
large protective polyglutamine aggregates. Actin could possibly be
involved in facilitating the addition of monomer to newly formed
aggregates. In assaying for [PSI+], ring cells containing functional
monomer not yet integrated into an aggregate would appear to be
[psi2].
Our data suggests that prion and polyglutamine formation
involves a multi-step process that is dependent upon actin
organization. Interestingly, six of the seven proteins identified
here have mammalian homologues (Table 2), suggesting that
similar mechanisms may be involved in aggregation and
oligomerization of QN-rich proteins in higher eukaryotes.
Further elucidation of how actin nucleation contributes to prion
induction will not only shed light on how toxic oligomeric species
are formed, but also could provide clues to the molecular
mechanisms underlying many human aggregating neurodegen-
erative diseases.
Methods
Plasmids and strains
In this work, 398 yeast deletion library strains (parent strain
BY4741: MATa ura3D his3D1 leu2D met15D; Open Biosystems,
Huntsville, AL; Table S1) previously obtained from an earlier
toxicity screen ([46]; Tyedmers and Lindquist unpublished) were
scored for effects on [PSI+] induction in a wildtype Sup35
background. The ‘‘kar1 plasmid donor’’ strain (GF667; MATa
CEN1–16::pGal1-CEN1–16-URA3Kl kar1D15 lys2 rad5-535 leu2-
3,112 can1-100 his3-11,15 trp1-1 cyhR) was used to introduce
plasmids and prions into the deletion library strains via
cytoduction, as described in Manogaran et al. [48]. A plasmid
containing a copper inducible prion and middle domain of Sup35
(Sup35PD) fused to green fluorescent protein (Sup35PD-GFP;
p1181: CEN2 HIS3 ori ARS AmpR pCup1-Sup35PD-GFP) was used to
induce [PSI+] in deletion strain derivates of BY4741, while a LEU2
version of the plasmid (p1182) was used in 74-D694 (L1749; [33];
MATa ade1–14 leu2–3,115 his3D200 ura3–52 trp1–289 high
[PIN+]). To score for [PSI+] in the BY4741 strains, a plasmid
containing the [PSI+] suppressible ura3–14 allele ([49]; p1513;
CEN2 LEU2 ura3–14 ori ARS AmpR) was used. A tester strain
(L2174; MATa leu2 ura2 his3 [pin-]) transformed with a copper
inducible RNQ1 fused to GFP (p1186; CEN LEU2 ori ARS AmpR
pCUP1-RNQ1:GFP) was used to confirm the presence of [PIN+] in
74D-694 deletion strains (see below). Plasmids p1572 and p1838
[52], which contain a fusion of GFP to the galactose inducible 25Q
or 103Q repeats in exon 1 of the huntingtin gene, respectively,
were used to examine polyglutamine aggregation and toxicity.
These fusion constructs do not contain the proline-rich region of
the huntingtin exon 1 [52].
Cultivation procedures
Yeast strains were cultivated using standard media and growth
protocols [71] and grown at 30oC except when indicated.
Complex media contained 2% dextrose (YPD), and synthetic
complete media contained the required amino acids and 2%
dextrose (SD) or 2% galactose (SGal).
Curing of BY4741 deletion strains
Pre-existing prions were cured by growing strains on media
containing low levels of guanidine hydrochloride (GuHCl), which
cures through the inactivation of Hsp104 [72,73]. Strains were
spotted onto YPD plates containing 5mM GuHCl and repeated
two to three additional times to ensure that prions were cured.
Preparation of the kar1 plasmid donor and introduction
of plasmids and prions into deletion strains
Prions and plasmids were introduced into the kar1 plasmid
donor strain. To make a [PSI+] kar1 plasmid donor strain to test for
[PSI+] maintenance in the deletion strains, the kar1 plasmid donor
strain was crossed to either a weak [PSI+] (L1759) or strong [PSI+]
(L1763) strain containing Sup35PD-GFP. kar1 plasmiductants
containing [PSI+] were chosen as described in Manogaran et al.
[48], and confirmed to contain [PSI+] by the formation of
Sup35PD-GFP aggregates after 16 hours. The [PSI+] kar1 plasmid
donor was mated to the BY4741 deletion strains, deletion strain
cytoductants were confirmed by testing for auxotrophic markers,
and the presence of [PSI+] Sup35PD-GFP aggregate formation
was examined as described above [54].
To test for the induction of [PSI+], prions and plasmids were
introduced into the kar1 plasmid donor strains by crossing to either
a [PIN+] (L1749 high [PIN+]) or [pin-] strain (L2910) containing the
Sup35PD-GFP and ura3–14 plasmids. [PIN+] kar1 plasmid donor
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strains were confirmed as above and tested for the presence of
[PIN+] by the formation of Sup35PD-GFP fluorescent rings after
24 hours of induction on copper [54]. Cytoduction of plasmids
and prions into the BY4741 library deletion strains has been
described previously [48]. To ensure reproducibility, cytoductions
were performed in duplicate.
Induction of [PSI+] in cytoduced deletion strains
Cytoduced BY4741 deletion strains, containing [PIN+] and both
Sup35PD-GFP (HIS3) and ura3–14 (LEU2) plasmids, were spotted
onto plasmid selective SD-His-Leu plates plus 50 mM copper sulfate
and grown for approximately two days. Strains were resuspended in
300 mL of sterile water and either spotted onto SD-Leu (grown two
days) to assess growth, or SD-Leu-Ura (grown at room temperature
for five to seven days) to score for [PSI+] induction. Induction
experiments on all 398 yeast deletion library strains were repeated
six times to ensure reproducibility. Spots that exhibited no or
reduced growth on SD-Leu-Ura, compared to controls, were
chosen as candidate genes that affect [PSI+] appearance (Table 1).
Re-engineering of candidate strains
Genetic recombination was used to replace candidate genes
(Table 1) with HIS3 in [PIN+] 74-D694. Primers (Table S2),
adjacent to sequences flanking the 59 or 39 ends of the candidate
gene, were used to PCR amplify the HIS3 gene. PCR products
were transformed and His+ transformants were confirmed for
insertion of the HIS3 gene in the correct locus. Two to three
independent knockout lines (Table S3) were obtained for each
deletion, except for pre9D. To confirm the presence of [PIN+],
deletion strains were mated to a [pin-] tester strain containing a
RNQ1-GFP plasmid. Diploids were checked for the formation of
fluorescent Rnq1-GFP aggregates after induction overnight. To
test whether las17D, vps5D, or sac6D maintain [PSI+], the deletions
were cytoduced with [PSI+] and checked for growth on –Ade.
Scoring the induction frequency of [PSI+]
Re-engineered deletion strains were transformed with the
Sup35PD-GFP (LEU2) plasmid and grown in SD-Leu plus copper
sulfate liquid media for 24 hours. After induction, approximately
10,000 cells were plated on SD–Ade, and a 50-fold dilution of cells
was plated on SD+12. Colony counts were obtained from at least
one transformant from each independent knock out (see Table S3)
on SD+12 vs. SD-Ade. Colony counts from at least three
transformants were used to determine the induction frequency.
Sup35PD-GFP ring formation in re-engineered deletion
strains
After 24 hours of induction, cells were examined for the
formation of GFP fluorescent rings [54] using a Zeiss Axioskop2
deconvolution workstation equipped with either a X40 Plan-
Neofluar or X100 Plan-Apochromat objective lens (Zeiss). Approx-
imately 300 cells were counted from at least one transformant from
each independent knock out, for a total of three transformants.
Determining cell viability of ring-containing cells
Ring containing cells were simultaneously visualized and
micromanipulated onto 2% sterile Noble Agar slabs. Slabs were
transferred onto YPD media and grown for one to two days.
Aggregation and toxicity of polyglutamine in
re-engineered deletion strains
Strains containing the galactose inducible 25Q or 103Q GFP
fusion plasmids were grown overnight in SD-Ura and then washed
in water approximately four times to remove residual glucose. To
score for aggregation, washed cells were grown in liquid Gal-Ura
for one to two hours with shaking and then examined for GFP
aggregates. To score for toxicity, log phase uninduced washed cells
were serially diluted 20-fold and spotted onto SD-Ura or SGal-
Ura.
Supporting Information
Figure S1 Certain deletion strains have decreased levels of
Sup35 and Sup35PD-GFP. [PIN+] wildtype or deletion strains
containing Sup35PD-GFP were grown for 22 hours to an
approximate OD600 3.0 at 30uC in the presence of 50 mM
copper. All strains are in the 74D-694 background except sac6D,
which is in the BY4741 background. Equivalent amounts of cell
lysates were loaded per lane and subjected to SDS-PAGE (see
Text S1). Lanes in the left panel were run on the same gel.
Blotted proteins were incubated either with anti-GFP antibody,
anti-Sup35 C-terminal antibody, or anti-PGK antibody (as
indicated).
Found at: doi:10.1371/journal.pgen.1001386.s001 (0.24 MB TIF)
Figure S2 The [PIN+] variant in the deletion strains appears to
be unaffected. [PIN+] wildtype and deletion strains, containing
Sup35PD-GFP, were grown for 24 hours in copper media, and
equivalent amounts of protein were loaded on a 1.5% agarose gel
and subjected to SDD-AGE [53]. Blotted proteins were incubated
with an antibody against the Rnq1 protein.
Found at: doi:10.1371/journal.pgen.1001386.s002 (0.62 MB TIF)
Figure S3 All deletion strains reach saturation after 24 hours of
induction, except las17D. Deletion and wildtype strains containing
Sup35PD-GFP and [PIN+] were grown in plasmid selective media
with copper at 30uC. OD600 readings were taken at the indicated
time points to assess growth.
Found at: doi:10.1371/journal.pgen.1001386.s003 (0.27 MB TIF)
Figure S4 Vacuole formation is altered in deletion strains,
except hog1D. A. Wildtype and deletion strains were incubated
with 5 mM FM4-64 for 20 minutes in YPD, washed and then
allowed to incubate for 60 minutes before visualizing internali-
zation of the dye. B. Wildtype cells were treated either with
DMSO (gray bars) or various concentrations of Nocodazole
(purple bars) during overnight induction of Sup35PD-GFP.
Percent of rings were calculated after 24 hours of induction.
C. Untreated cells (DMSO) or cells treated with 50 ug/ml of
Nocodazole from (B) were plated in 20 fold serial dilutions on
SD-Ade media to score for [PSI+] induction. Growth on SD+Ade
indicates there is no growth defect.
Found at: doi:10.1371/journal.pgen.1001386.s004 (0.98 MB TIF)
Table S1 Candidate deletions screened for [PSI+] induction.
Found at: doi:10.1371/journal.pgen.1001386.s005 (0.16 MB
DOC)
Table S2 Primers used in re-engineering deletion candidates in
the 74-D694 genetic background.
Found at: doi:10.1371/journal.pgen.1001386.s006 (0.05 MB
DOC)
Table S3 Re-engineered independent knock out lines in the 74-
D694 background used in this study.
Found at: doi:10.1371/journal.pgen.1001386.s007 (0.05 MB
DOC)
Text S1 Supporting information methods.
Found at: doi:10.1371/journal.pgen.1001386.s008 (0.05 MB
DOC)
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